# Mesalamine

NDC: 0378-1375
Generic name: mesalamine
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20191126

FDA application: ANDA207271

## Active ingredients

- MESALAMINE: .375 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-1375"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-1375
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8b93ea3-0367-4605-b87f-06c3812ff3b7